Michael Auerbach
Director at ATAI Life Sciences N.V. (ATAI)
Michael Auerbach has filed 10 insider reports with the SEC since February 2021, as director at ATAI Life Sciences N.V. (ATAI) and director at Tilray, Inc. (TLRY). The latest filing, on June 14, 2024, reports grant or award at ATAI Life Sciences N.V. (ATAI).
- Filings
- 10
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Michael Auerbach is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 4,666 | Jun 14, 2024 | |||||
| Director | 333,665 | $2.65 | May 6, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 13, 2024ATAISEC Form 4 filed by Director Auerbach MichaelForm 4Grant or award
- May 23, 2023ATAISEC Form 4 filed by Auerbach MichaelForm 4Grant or award
- May 25, 2022ATAISEC Form 4 filed by Auerbach MichaelForm 4Grant or award
- Jan 14, 2022ATAISEC Form 4: Auerbach Michael disposed of 5,559,808 sharesForm 4Other acquisition or disposition
- Sep 10, 2021ATAISEC Form 4 filed by Auerbach MichaelForm 4Grant or award
- Apr 30, 2021TLRYSEC Form 4: Auerbach Michael exercised 52,622 units of Class 2 Common Stock at a strike of $0.00, increasing direct ownership by 19% to 333,665 unitsForm 4Exercise or conversion of a derivative
- Apr 1, 2021TLRYSEC Form 4: Michael Auerbach exercised 2,188 units of Class 2 Common Stock at a strike of $0.00, increasing direct ownership by 0.78% to 281,043 unitsForm 4Exercise or conversion of a derivative
- Mar 16, 2021TLRYSEC Form 4 filed by Michael AuerbachForm 4Other acquisition or disposition
- Feb 23, 2021TLRYSEC Form 4 filed by Michael AuerbachForm 4Other acquisition or disposition
- Jan 25, 2021TLRYSEC Form 4: Michael Auerbach decreased ownership by 0.16% to 278,855 unitsForm 4Other acquisition or disposition
Compare Michael Auerbach with
- Michael Auerbach vs Kevin James Craig1 shared
- Michael Auerbach vs Gerd Kochendoerfer1 shared
- Michael Auerbach vs Barrett Christopher Ryan Cave1 shared
- Michael Auerbach vs Glenn Frank Short1 shared
- Michael Auerbach vs John Francis Hoffman1 shared
- Michael Auerbach vs Michael E. Faerm1 shared
Other insiders at the same companies
- Kevin James CraigATAI
- Gerd KochendoerferATAI
- Sabrina Martucci JohnsonATAI
- John Francis HoffmanATAI
- Anne Nagengast JohnsonATAI
- Christian AngermayerATAI
- Srinivas RaoATAI
- Glenn Frank ShortATAI
- Laurent FischerATAI
- Scott BraunsteinATAI
- Barrett Christopher Ryan CaveATAI
- Robert HershbergATAI
- Michael E. FaermATAI
- Andrea Heslin SmileyATAI
- Amir H KalaliATAI
- Irwin D SimonTLRY
Questions about Michael Auerbach
- What is Michael Auerbach's role at ATAI Life Sciences N.V.?
- Michael Auerbach reports to the SEC as director at ATAI Life Sciences N.V. (ATAI), according to the latest filing on June 14, 2024. Michael Auerbach has also filed as director at Tilray, Inc. (TLRY).
- How many shares does Michael Auerbach own?
- After the latest filing that states it, Michael Auerbach directly owned 4,666 shares of ATAI Life Sciences N.V. (ATAI) and 333,665 shares of Tilray, Inc. (TLRY). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael Auerbach bought or sold stock recently?
- No open-market purchases or sales by Michael Auerbach are on file. The filings report grant or award, other acquisition or disposition and exercise or conversion of a derivative.
- How do I get alerts when Michael Auerbach files?
- Follow Michael Auerbach on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael Auerbach (SEC CIK 0001746080). Totals count each trade once, skipping amendments whose original is on file, from Feb 17, 2021 on. View on SEC EDGAR